ADVANCES AND CHALLENGES IN BIOPHARMACEUTICS: BRIDGING DRUG FORMULATION AND THERAPEUTIC EFFICACY

Kurbanova Mavluda Rozikovna

Authors

Kurbanova Mavluda Rozikovna Lecturer in Biophamacy Department of General Subjects Asia International University Bukhara, Uzbekistan

Keywords:

biopharmaceutics, bioavailability, pharmacokinetics, drug delivery systems, BCS classification, nanotechnology, personalized medicine

Abstract

Biopharmaceutics is a critical discipline within pharmaceutical sciences that examines the relationship between the physicochemical properties of drug substances, dosage forms, and their biological performance. This field integrates principles of pharmaceutics, pharmacokinetics, and drug delivery to optimize therapeutic outcomes. The present article explores the fundamental concepts of biopharmaceutics, including drug absorption, bioavailability, and the Biopharmaceutics Classification System (BCS). It also highlights recent advancements, such as nanotechnology-based delivery systems and personalized medicine approaches, while addressing current challenges in drug development and regulatory evaluation.

References

Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995). A theoretical basis for a biopharmaceutics drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research, 12(3), 413–420.

Dressman, J. B., & Reppas, C. (2000). In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs. European Journal of Pharmaceutical Sciences, 11(Suppl 2), S73–S80.

Shargel, L., Wu-Pong, S., & Yu, A. B. C. (2012). Applied Biopharmaceutics and Pharmacokinetics (6th ed.). McGraw-Hill Education.

Sinko, P. J. (2011). Martin’s Physical Pharmacy and Pharmaceutical Sciences (6th ed.). Lippincott Williams & Wilkins.

Aulton, M. E., & Taylor, K. M. G. (2018). Aulton’s Pharmaceutics: The Design and Manufacture of Medicines (5th ed.). Elsevier.

United States Food and Drug Administration (FDA). (2020). Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System.

European Medicines Agency (EMA). (2010). Guideline on the Investigation of Bioequivalence.

Löbenberg, R., & Amidon, G. L. (2000). Modern bioavailability, bioequivalence and biopharmaceutics classification system: New scientific approaches to international regulatory standards. European Journal of Pharmaceutics and Biopharmaceutics, 50(1), 3–12.

Müller, R. H., Shegokar, R., & Keck, C. M. (2011). 20 years of lipid nanoparticles (SLN & NLC): Present state of development and industrial applications. Current Drug Discovery Technologies, 8(3), 207–227.

Torchilin, V. P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nature Reviews Drug Discovery, 4(2), 145–160.